Debu Tripathy, MD, Co-Leader, Women's Cancer Program, Norris Comprehensive Cancer Center, University of Southern California, discusses two important trials in breast cancer looking at extended hormonal therapy.
Videos
Pamela Crilley, DO, explains the benefits and downfalls of prescribing tyrosine kinase inhibitors for the treatment of CML.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 Highlights: Breast & Lung Cancer Advances With Ajaz Khan, MD
2
Sunvozertinib Outperforms Chemotherapy as First-Line Therapy for EGFR Exon 20–Mutant NSCLC
3
ASCO Roundup: Rare Melanomas and Skin Cancers
4
FDA Grants RMAT Designation to Lasme-Cel for Relapsed/Refractory B-ALL
5